Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | Valuation Score | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $14.10 | $4.88 | 189.20% | 156.67x | -21.04x | 8.57x | 13.57x | 1.13x | -$31.41M | -1.57% | $160.50M | 1.13 | $2.19B | 84.69 | |
| KRYS | KRYSTAL BIOTECH INC | $157.25 | $9.60 | 1,537.55% | 393.13x | -55.57x | 84.23x | 5.71x | 7.43x | -$603.00k | -0.01% | $778.64M | 28.68 | $4.10B | 228.93 | |
| GMAB | GENMAB A | $28.97 | $21.65 | 33.81% | 29.87x | 17.56x | 7.98x | 4.16x | 0.62x | $1.02B | 5.33% | $4.60B | 6.96 | $17.09B | N/A | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $29.35 | $43.85 | -33.07% | 13.53x | 7.60x | 3.00x | 3.57x | 0.32x | $219.08M | 12.55% | $466.99M | 7.85 | $1.55B | 6.99 | |
| INCY | INCYTE CORP | $51.92 | $63.97 | -18.84% | 19.45x | 8.74x | 3.14x | 2.25x | 0.37x | $464.00M | 4.00% | $5.19B | 23.21 | $8.47B | 9.22 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $89.49 | $34.39 | 160.23% | 100.55x | 31.85x | 6.95x | 3.41x | 1.06x | $62.57M | 0.37% | $4.95B | 26.36 | $17.22B | 55.49 | |
| CORT | CORCEPT THERAPEUTICS INC | $22.30 | $16.30 | 36.79% | 21.86x | 15.93x | 4.79x | 4.56x | 0.73x | $126.90M | 5.49% | $506.71M | 4.89 | $2.17B | 19.94 | |
| HALO | HALOZYME THERAPEUTICS INC | $38.71 | $47.87 | -19.14% | 18.17x | 9.49x | 6.16x | 58.58x | 0.37x | $373.28M | 7.31% | $83.81M | 0.64 | $6.29B | 13.92 | |
| MDXG | MIMEDX GROUP INC | $6.36 | $5.76 | 10.40% | 15.90x | 127.20x | 2.30x | 6.55x | 0.62x | $24.79M | 3.35% | $142.72M | 1.23 | $900.75M | 27.65 | |
| VNDA | VANDA PHARMACEUTICALS INC | $4.80 | $1.65 | 191.17% | 120.00x | 17.78x | 1.43x | 0.51x | 1.18x | $12.42M | 4.50% | $544.91M | 9.50 | $147.36M | 15.76 | |
| RPRX | ROYALTY PHARMA PLC | $27.82 | $41.84 | -33.51% | 10.95x | 6.90x | 5.29x | 1.65x | 0.35x | $2.98B | 23.89% | $10.08B | 22.53 | $22.28B | 16.85 | |
| EXEL | EXELIXIS INC | $22.87 | $16.22 | 40.97% | 35.18x | 14.20x | 3.98x | 3.06x | 0.63x | $292.86M | 4.02% | $2.26B | 7.12 | $6.86B | 21.98 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | $1.98 | $40.38 | -95.10% | 2.71x | 0.64x | 0.35x | 0.31x | 0.02x | $10.68M | 8.03% | $433.43M | 6.45 | -$32.47M | -0.59 | |
| PBYI | PUMA BIOTECHNOLOGY INC | $5.17 | $7.14 | -27.63% | 11.24x | 8.21x | 1.03x | 4.66x | 0.39x | $26.87M | 11.03% | $53.44M | 1.13 | $276.14M | 5.81 | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $108.83 | $183.41 | -40.66% | 16.62x | 4.49x | 1.80x | 1.82x | 0.26x | $1.07B | 15.51% | $3.74B | 59.05 | $11.05B | 9.04 | |
| BNTX | BIONTECH SE | $88.01 | $77.34 | 13.80% | 20.92x | 18.57x | 5.04x | 0.95x | 0.57x | $5.07B | 24.24% | $22.01B | 92.57 | $8.98B | 5.93 | |
| TECH | BIO-TECHNE CORP | $62.80 | $22.21 | 182.71% | 44.54x | 26.06x | 8.64x | 5.03x | 1.52x | $225.39M | 2.28% | $1.96B | 12.46 | $10.30B | 27.61 | |
| NVO | NOVO NORDISK A S | $125.26 | $19.45 | 544.09% | 46.09x | 51.65x | 16.71x | 36.42x | 9.68x | $12.10B | 2.14% | $15.51B | 3.44 | $566.76B | 34.02 | |
| CPRX | CATALYST PHARMACEUTICALS INC | $15.10 | $7.55 | 99.94% | 22.54x | 16.78x | 4.03x | 4.59x | 1.36x | $143.37M | 8.93% | $387.88M | 3.65 | $1.65B | 12.89 | |
| UTHR | UNITED THERAPEUTICS CORP | $234.06 | $180.11 | 29.95% | 11.12x | 12.13x | 4.71x | 1.84x | 1.27x | $747.60M | 6.82% | $5.98B | 127.88 | $10.51B | 7.58 | |
| REGN | REGENERON PHARMACEUTICALS INC | $900.16 | $266.18 | 238.18% | 24.30x | 22.15x | 7.32x | 3.80x | 5.01x | $3.88B | 4.03% | $25.97B | 243.42 | $98.78B | 21.05 | |
| VRTX | VERTEX PHARMACEUTICALS INC | $399.92 | $89.18 | 348.43% | 28.46x | 29.43x | 10.44x | 5.88x | 11.60x | $3.34B | 3.24% | $17.58B | 68.22 | $93.66B | 20.34 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.